【24h】

An In Vitro Study of Nano-fiber Polymers for Guided Vascular Regeneration

机译:引导性血管再生的纳米纤维聚合物的体外研究

获取原文
获取原文并翻译 | 示例

摘要

Biomaterials that successfully integrate into surrounding tissue should match not only the tissue's mechanical properties, but also the dimensions of the associated nano-structured extracellular matrix (ECM) components. The goal of this research was to use these ideals to develop a synthetic, nano-structured, polymeric biomaterial that has cytocompatible and mechanical behaviors similar to that of natural vascular tissue. In a novel manner, poly-lactic acid/poly-glycolic acid (PLGA) (50/50 wt.% mix) and polyurethane were separately synthesized to possess a range of fiber dimensions in the micron and nanometer regime. Preliminary results indicated that decreasing fiber diameter on both PLGA and PU enhanced arterial smooth muscle cell adhesion; specifically, arterial smooth muscle cell adhesion increased 23% when PLGA fiber dimensions decreased from 500 to 50 nm and increased 76% on nano-structured, compared to conventional structured, polyurethane. However, nano-structured PLGA decreased endothelial cell adhesion by 52%, whereas adhesion of these same cells was increased by 50% on polyurethane. For these reasons, the present in vitro study provides the first evidence that polymer fiber dimensions can be used to selectively control cell functions for vascular prosthesis.
机译:成功整合到周围组织中的生物材料不仅应与组织的机械性能匹配,而且应与相关的纳米结构的细胞外基质(ECM)组件的尺寸匹配。这项研究的目的是利用这些理想来开发具有类似于天然血管组织的细胞相容性和机械行为的合成的,纳米结构的聚合物生物材料。以新颖的方式,分别合成了聚乳酸/聚乙醇酸(PLGA)(50/50重量%的混合物)和聚氨酯,以在微米和纳米范围内具有一定范围的纤维尺寸。初步结果表明,减小PLGA和PU上的纤维直径可增强动脉平滑肌细胞的黏附力。具体而言,与常规结构化聚氨酯相比,当PLGA纤维尺寸从500 nm减小到50 nm时,动脉平滑肌细胞粘附增加23%,而在纳米结构上增加76%。但是,纳米结构的PLGA使内皮细胞的粘附力降低了52%,而在聚氨酯上,这些相同细胞的粘附力却提高了50%。由于这些原因,本体外研究提供了第一个证据,即聚合物纤维的尺寸可用于选择性控制血管修复的细胞功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号